Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration

Cancer Lett. 1990 Jun 15;51(3):193-201. doi: 10.1016/0304-3835(90)90102-4.

Abstract

A series of CCRF-CEM sublines selected for extreme resistance to methotrexate has been shown previously to exhibit cross resistance to a number of agents belonging to the multidrug resistance phenotype. The mechanism(s) underlying resistance to vincristine, vinblastine and actinomycin D in the most resistant subline (CEM/MTX R3) has now been investigated. Efflux of [3H]vincristine was more rapid in CEM/MTX R3 than in either CCRF-CEM cells or a methotrexate-resistant subline not refractory to Vinca alkaloids. In addition, verapamil completely reversed resistance to vincristine, vinblastine and actinomycin D in the CEM/MTX R3 cells. While these results are suggestive of P-glycoprotein-mediated multidrug resistance, Northern analysis revealed no detectable expression of the mdr 1/gene in CEM/MTX R3 cells. Likewise, karyotypic analysis of the resistant subline, while revealing certain clonal abnormalities, provided no evidence of alteration in the mdr 1/gene locus on chromosome 7. The data suggest therefore the operation, in these cells, of a novel mechanism of resistance.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Cell Survival / drug effects
  • Dactinomycin / pharmacology
  • Drug Resistance / genetics*
  • Humans
  • Karyotyping
  • Leukemia / drug therapy
  • Leukemia / genetics*
  • Membrane Glycoproteins / analysis
  • Methotrexate / pharmacology*
  • Phenotype
  • Tumor Cells, Cultured / drug effects
  • Verapamil / pharmacology
  • Vinblastine / pharmacology
  • Vincristine / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Membrane Glycoproteins
  • Dactinomycin
  • Vincristine
  • Vinblastine
  • Verapamil
  • Methotrexate